These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 36674943)

  • 1. Anti-HIV Potential of Beesioside I Derivatives as Maturation Inhibitors: Synthesis, 3D-QSAR, Molecular Docking and Molecular Dynamics Simulations.
    Zhao Z; Ma Y; Li X; Morris-Natschke SL; Sun Z; Sun Z; Ma G; Dong Z; Zhao X; Yang M; Xu X; Lee K; Wu H; Chen C
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction of a HIV-1 subtype C 3D model using homology modeling and in-silico docking, molecular dynamics simulation, and MM-GBSA calculation of second-generation HIV-1 maturation inhibitor(s).
    K C Y; Pal S; Nitz TJ; Wild C; Gaur R
    J Biomol Struct Dyn; 2024 Sep; 42(14):7150-7159. PubMed ID: 37489057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alkyl Amine Bevirimat Derivatives Are Potent and Broadly Active HIV-1 Maturation Inhibitors.
    Urano E; Ablan SD; Mandt R; Pauly GT; Sigano DM; Schneider JP; Martin DE; Nitz TJ; Wild CT; Freed EO
    Antimicrob Agents Chemother; 2016 Jan; 60(1):190-7. PubMed ID: 26482309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New Phosphorus Analogs of Bevirimat: Synthesis, Evaluation of Anti-HIV-1 Activity and Molecular Docking Study.
    Chrobak E; Marciniec K; Dąbrowska A; Pęcak P; Bębenek E; Kadela-Tomanek M; Bak A; Jastrzębska M; Boryczka S
    Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31640137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanistic Studies and Modeling Reveal the Origin of Differential Inhibition of Gag Polymorphic Viruses by HIV-1 Maturation Inhibitors.
    Lin Z; Cantone J; Lu H; Nowicka-Sans B; Protack T; Yuan T; Yang H; Liu Z; Drexler D; Regueiro-Ren A; Meanwell NA; Cockett M; Krystal M; Lataillade M; Dicker IB
    PLoS Pathog; 2016 Nov; 12(11):e1005990. PubMed ID: 27893830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of an HIV-1 maturation inhibitor on the structure and dynamics of CA-SP1 junction helices in virus-like particles.
    Gupta S; Louis JM; Tycko R
    Proc Natl Acad Sci U S A; 2020 May; 117(19):10286-10293. PubMed ID: 32341150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insight into the mechanism of action of EP-39, a bevirimat derivative that inhibits HIV-1 maturation.
    Neyret A; Gay B; Cransac A; Briant L; Coric P; Turcaud S; Laugâa P; Bouaziz S; Chazal N
    Antiviral Res; 2019 Apr; 164():162-175. PubMed ID: 30825471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural and functional insights into the HIV-1 maturation inhibitor binding pocket.
    Waki K; Durell SR; Soheilian F; Nagashima K; Butler SL; Freed EO
    PLoS Pathog; 2012; 8(11):e1002997. PubMed ID: 23144615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probing the binding mechanism of substituted pyridine derivatives as effective and selective lysine-specific demethylase 1 inhibitors using 3D-QSAR, molecular docking and molecular dynamics simulations.
    Wang ZZ; Yang J; Sun XD; Ma CY; Gao QB; Ding L; Liu HM
    J Biomol Struct Dyn; 2019 Aug; 37(13):3482-3495. PubMed ID: 30175693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphate Derivatives of 3-Carboxyacylbetulin: SynThesis, In Vitro Anti-HIV and Molecular Docking Study.
    Marciniec K; Chrobak E; Dąbrowska A; Bębenek E; Kadela-Tomanek M; Pęcak P; Boryczka S
    Biomolecules; 2020 Aug; 10(8):. PubMed ID: 32764519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3D QSAR, Docking, Molecular Dynamics Simulations and MM-GBSA studies of Extended Side Chain of the Antitubercular Drug (6S) 2-Nitro-6- {[4-(trifluoromethoxy) benzyl] oxy}-6,7-dihydro-5H-imidazo[2,1-b] [1,3] oxazine.
    Chaudhari HK; Pahelkar A
    Infect Disord Drug Targets; 2019; 19(2):145-166. PubMed ID: 30324898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prototype HIV-1 maturation inhibitor, bevirimat, binds to the CA-SP1 cleavage site in immature Gag particles.
    Nguyen AT; Feasley CL; Jackson KW; Nitz TJ; Salzwedel K; Air GM; Sakalian M
    Retrovirology; 2011 Dec; 8():101. PubMed ID: 22151792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insights into the activity of maturation inhibitor PF-46396 on HIV-1 clade C.
    Ghimire D; Timilsina U; Srivastava TP; Gaur R
    Sci Rep; 2017 Mar; 7():43711. PubMed ID: 28252110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-Activity Relationships of the Human Immunodeficiency Virus Type 1 Maturation Inhibitor PF-46396.
    Murgatroyd C; Pirrie L; Tran F; Smith TK; Westwood NJ; Adamson CS
    J Virol; 2016 Sep; 90(18):8181-97. PubMed ID: 27384665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In silico study on indole derivatives as anti HIV-1 agents: a combined docking, molecular dynamics and 3D-QSAR study.
    Balupuri A; Gadhe CG; Balasubramanian PK; Kothandan G; Cho SJ
    Arch Pharm Res; 2014 Aug; 37(8):1001-15. PubMed ID: 24338530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacophore generation, atom-based 3D-QSAR, molecular docking and molecular dynamics simulation studies on benzamide analogues as FtsZ inhibitors.
    Tripathy S; Azam MA; Jupudi S; Sahu SK
    J Biomol Struct Dyn; 2018 Sep; 36(12):3218-3230. PubMed ID: 28938860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The capsid-spacer peptide 1 Gag processing intermediate is a dominant-negative inhibitor of HIV-1 maturation.
    Checkley MA; Luttge BG; Soheilian F; Nagashima K; Freed EO
    Virology; 2010 Apr; 400(1):137-44. PubMed ID: 20172577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rational Design of Colchicine Derivatives as anti-HIV Agents via QSAR and Molecular Docking.
    Worachartcheewan A; Songtawee N; Siriwong S; Prachayasittikul S; Nantasenamat C; Prachayasittikul V
    Med Chem; 2019; 15(4):328-340. PubMed ID: 30251609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological evaluation of a new derivative of bevirimat that targets the Gag CA-SP1 cleavage site.
    Coric P; Turcaud S; Souquet F; Briant L; Gay B; Royer J; Chazal N; Bouaziz S
    Eur J Med Chem; 2013 Apr; 62():453-65. PubMed ID: 23399723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A single G10T polymorphism in HIV-1 subtype C Gag-SP1 regulates sensitivity to maturation inhibitors.
    Ghimire D; Kc Y; Timilsina U; Goel K; Nitz TJ; Wild CT; Gaur R
    Retrovirology; 2021 Apr; 18(1):9. PubMed ID: 33836787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.